PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model-Reference-Cited by-同舟云学术

PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model

Published:2020-09 Issue: Volume:18 Page:226-235
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Alzubi Jamal,Dettmer-Monaco Viviane,Kuehle Johannes,Thorausch Niko,Seidl Maximilian,Taromi Sanaz,Schamel Wolfgang,Zeiser Robert,Abken Hinrich,Cathomen Toni^ORCID,Wolf Philipp

Funder

Horizon 2020 Programme of the European Commission

German Federal Ministry of Education and Research

Research Commission of the Faculty of Medicine of the Albert-Ludwigs-University of Freiburg

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference53 articles.

1. The diagnosis and treatment of prostate cancer: a review;Litwin;JAMA,2017

2. Prostate cancer incidence in 43 populations worldwide: an analysis of time trends overall and by age group;Zhou;Int. J. Cancer,2016

3. The making and function of CAR cells;Zabel;Immunol. Lett.,2019

4. Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia;Park;N. Engl. J. Med.,2018

5. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia;Maude;N. Engl. J. Med.,2018

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Left out in the cold: Moving beyond hormonal therapy for the treatment of immunologically cold prostate cancer with CAR T cell immunotherapies;The Journal of Steroid Biochemistry and Molecular Biology;2024-10

2. Targeting endothelial cell anergy to improve CAR T cell therapy for solid tumors;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

3. Engineering of potent CAR NK cells using non-viral Sleeping Beauty transposition from minimalistic DNA vectors;Molecular Therapy;2024-07

4. PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial;Nature Medicine;2024-06

5. Molecular understanding and clinical outcomes of CAR T cell therapy in the treatment of urological tumors;Cell Death & Disease;2024-05-24